SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

Cervical cancer jab researcher warns of risks

By Leave a Comment

Irish Examiner.com

By Jennifer Hough

Monday, August 30, 2010

THE leading researcher in the development of the cervical cancer vaccine, Gardasil, has called it a “public health experiment” and has warned that parents must be made aware of the serious adverse events associated with its use.

The vaccination programme is set to be rolled out here next month, targeting first- and second-year secondary school students.

However, Dr Diane Harper, who carried out safety studies to get Gardasil approved, warned of “serious adverse events including death” associated with it.

Gardasil®: When a Placebo is Not a Placebo

By Leave a Comment

By Hilary and Peter Butler from their book From One Prick To Another, (2008)

In times long since gone, any pharmaceutical product used to be tested for safety, with one group of people using the drug and another group, the “control” group, using a placebo.

A placebo, in the context of a drug trial, was represented by an “inert” substance; something which had absolutely no impact on any biochemical, immunological or other measurable function in the body. In this way, the studies used to compare any adverse biological “effect” of the drug against the effect of nothing.

A 16-Year-Old Girl With Bilateral Visual Loss and Left Hemiparesis Following an Immunization Against Human Papilloma Virus

By Leave a Comment

Journal of Child Neurology
J Child Neurol 2010; 25; 321
DOI: 10.1177/0883073809349322

Received August 11, 2009. Received revised August 26, 2009. Accepted
for publication August 26, 2009.

Francis J. DiMario, Jr, Mirna Hajjar and Thomas Ciesielski

We report the course of a 16-year-old girl who presented with near complete visual loss associated with chiasmal neuritis and a biopsy proven tumefactive demyelinating lesion on magnetic resonance imaging (MRI) in association with a recent immunization against human papilloma virus.

Suspected Adverse Reaction Analysis CERVARIX Human papillomavirus (HPV) vaccine

By Leave a Comment

MHRA

December 3, 2009

This report summarises the adverse reactions suspected to have been caused by Cervarix human papillomavirus (HPV) vaccine in the UK. This includes reports received between 14 April 2008 and 2 December 2009. These reports have been voluntarily submitted to the MHRA by healthcare professionals and members of the public via the Yellow Card Scheme (visit HTUTUwww.yellowcard.gov.ukUTH) and by the manufacturers of the vaccine as part of their legal requirements.

Vertical transmission of the human papillomavirus: a systematic quantitative review

By Leave a Comment

Transmissão vertical do papilomavírus humano:
uma revisão sistemática quantitativa

1006 REVISÃO REVIEW

Lidia Rosi Medeiros 1
Anaelena Bragança de Moraes Ethur 1
Juliana Balbinot Hilgert 1
Roselaine Ruviaro Zanini 1
Otávio Berwanger 1,2
Mary Clarisse Bozzetti 3,4
Luciane Calil Mylius 3

In order to better understand the exact mode and risk of vertical transmission in asymptomatic pregnant women, as well as the relationship between HPV transmission and mode of delivery,we have proposed this systematic quantitative review of prospective cohort studies. A comprehensive search was performed in the Cochrane Library,MEDLINE, LILACS, CANCERLIT,and EMBASE, as well as in the reference lists from the identified studies.

News

Videos

Contact